General Announcment under regulation 30 of SEBI (LODR) 2015.

Date: 05.10.2026 The Manager Listing Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai – 400001 Scrip Code: 531676 Security ID: EMROCK Subject: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – For investment in EMROCK LIFESCIENCE LLP (LLPIN-ADC-8815) . Dear Sir/Madam, Pursuant to the provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, read with Schedule III of the SEBI (LODR) Regulations, 2015, we hereby inform that the Company has made contribution 50.50% in the Capital of Emrock Lifescience LLP (LLPIN-ADC-8815) as a subscribing partner. The investment has been made as part of the Company’s strategic initiative to invest in Pharmaceutical Projects. Further details will be disclosed as and when required under applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Kindly take the same on record. Thanking You. FOR, EMROCK CORPORATION LIMITED (Formerly VAGHANI TECHNO - BUILD LIMITED) PARTH TULSIBHAI PATEL DIRECTOR & CFO DIN: 07289967 Annexure – A Details as required under Regulation 30 of the Listing Regulations and the SEBI Circular No. SEBI/HO/CFD/CFD-PoD-1/P/CIR/2023/123 dated July 13, 2023, is provided below: Details of Limited Liability Partnership Sr No. Particulars Details 1 Name of the target entity, details in brief Emrock LIfescience LLP Incorporated on such as size, turnover, etc. 05.10.2026 Total Obligation of LLP in Rs. 100,000 Emrock Corporatioan Ltd Obligation to subscribe to capital Rs. 50500/- Turnover for the year: Not applicable being newly incorporated. Whether the incorporation would fall Emrock Lifescience LLP is 2 within related party transaction(s) and promoted by Emrock Corporation whether the promoter /promoter group/ Limited being subscriber to the LLP. group companies have any interest in the Therefore, it will fall under related party entity being acquired. If yes, nature of transactions. Directors of Emrock interest and details thereof and whether the Corporation Limited Mr. Arjunbhai same is done at "arm's length". Jagdishbhai Patel and Mr. Parth Tulsibhai Patel are also Designated Partners of Emrock Lifescience LLP 3 Industry to which the entity being acquired Pharmaceuticals belongs. 4 Objects and effects of Incorporation The investment has been made as part of (including but not limited to, disclosure of the Company’s strategic initiative to reasons for acquisition of target entity, if its invest in Pharmaceutical Projects. business is outside the main line of business of the listed entity). 5 Brief details of any governmental or regulatory Not applicable approvals required for the Incorporation. 6 Indicative time period for Not applicable completion of the acquisition 7 Nature of consideration - whether cash consideration or share swap and details of Cash towards contribution to capital the same. 8 Cost of acquisition or the price at which the Rs. 50500/- as partners contribution shares are acquired. Percentage of shareholding /control EMROCK CORPORATION LTD, is to acquired and/ or number of shares acquired invest 50.50% in contribution as partner of EMROCK LIFESCIENCE LLP. 9 Brief background about the entity acquired EMROCK LIFESCIENCE LLP is in terms of products / line of business incorporated on incorporated on 5th acquired, date of incorporation, history of October , 2026, to carry on business of last 3 years turnover, country in which the manufacturing, processing, formulating, acquired entity has presence and any other importing, exporting, trading, marketing, significant information (in brief) distributing, wholesaling and retailing of pharmaceutical, medicinal, healthcare, nutraceutical and allied products, including bulk drugs, APIs, drug intermediates, formulations, antibiotics, vitamins, vaccines and veterinary medicines having registered address at Regd office . 715, ACCOLADE-2, S NO. 750/2/2, F.P. 131, SOLA, Ahmedabad, Gujarat, India, 380060 Turnover for the year 2025-26 Not applicable Turnover of the year 2024-25 Not applicable Turnover of the year 2023-24 Not applicable Kindly take the same on your records and oblige. Thanking you, Yours faithfully, FOR, EMROCK CORPORATION LIMITED (Formerly VAGHANI TECHNO - BUILD LIMITED) PARTH TULSIBHAI PATEL Director & CFO DIN: 07289967 Place : Ahmedabad